Skip to content

Terrance P. Coyne, EVP & CFO at Royalty Pharma, sold RPRX on Aug 13, 2026

Data as of Oct 16

▼ SELL$105K1,772 shares at $59.14Terrance P. Coyne EVP & CFORPRX Royalty Pharma plc
Watch RPRX
Traded
Aug 13, 2026
Disclosed
Aug 17, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Terrance P. Coyne, EVP & CFO at Royalty Pharma, sold RPRX on Aug 13, 2026TRADEDDISCLOSED
RPRXSimilar stocks (XLV — its sector index fund), rebased to RPRX's price on the disclosure day
RPRX since disclosure
+2.5%
after the sale
Similar stocks (XLV) since disclosure
+5.8%
XLV — its sector index fund

Change in closing price from Aug 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLTerrance P. Coyne EVP & CFORPRX Royalty Pharma plc$541Kdisclosed Aug 17 · filed 4 days after the trade

See every trade on RPRX →